The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
ASLAN Pharmaceuticals Limited(NASDAQ:ASLN) 
ASLAN Pharmaceuticals Limited, a clinical-stage immunology and oncology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatit...
Website: http://www.aslanpharma.com
Founded: 2010
IPO Price: $8.05 (Dec 03, 2019)
Sector: Healthcare
Industry: Biotechnology
ASLAN Pharmaceuticals Days Receivable Outstanding ttm (DSO)
ASLAN Pharmaceuticals Op Cashflow Per Share ttm
ASLAN Pharmaceuticals Free Cashflow Per Share ttm
ASLAN Pharmaceuticals Cash Per Share ttm
ASLAN Pharmaceuticals P/S ratio ttm
ASLAN Pharmaceuticals (GAAP) P/E ratio ttm
ASLAN Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.